Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Fibroblast growth factor 15 overexpression and combined peroxisome proliferator–activated receptor α activation attenuates metabolic dysfunction–associated steatohepatitis progression in mice

Drug Metabolism and Disposition(2025)10.1016/j.dmd.2025.100128Source: DataRank Database

Fibroblast growth factor 15 overexpression and combined peroxisome proliferator–activated receptor α activation attenuates metabolic dysfunction–associated steatohepatitis progression in mice is a research paper published in Drug Metabolism and Disposition (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.00)OA: hybridTopics (39)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Mary Stofan ORCID,Bo Kong ORCID,Rulaiha Taylor ORCID,Zakiyah Henry ORCID,Syeda Maliha ORCID

Live enrichment

PubMed:40815899 PMC:PMC12597547 OpenAlex:https://openalex.org/W4412828293

U.S. Department of Veterans Affairs

Grant: I01 BX002741

National Institute of Environmental Health Sciences

Grant: R21 ES029258

NIH National Institute of General Medical Sciences

Grant: R01 GM135258

NIEHS NIH HHS

Grant: T32 ES007148

FWCI

0.00

Citation Percentile

0.1%

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.dmd.2025.100128

publisherhttps://doi.org/10.1016/j.dmd.2025.100128

publisherhttps://api.elsevier.com/content/article/PII:S0090955625091378?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0090955625091378?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40815899

Fields of Study

Fibroblast Growth Factor ResearchKruppel-like factors researchEpigenetics and DNA MethylationAnimalsFibroblast Growth FactorsPPAR alphaMiceMice, TransgenicDiet, High-FatFatty LiverMaleMice, Inbred C57BLLiverDisease ProgressionNon-alcoholic Fatty Liver Disease

MeSH Terms

AnimalsFatty LiverFibroblast Growth FactorsLiverMaleMice, Inbred C57BLMice, TransgenicDisease ProgressionPPAR alphaMiceDiet, High-FatNon-alcoholic Fatty Liver Disease

Keywords

PharmacologyChemistryPeroxisome proliferator-activated receptorCancer researchReceptorBiologyBiochemistryBile acidfarnesoid X receptorPeroxisome Proliferator–activated Receptor ΑFibroblast Growth Factor 15Metabolic Dysfunction–associated Steatohepatitis

Sustainable Development Goals

SDG 0: Zero hunger